Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study

Maria Rosaria Valerio, Marco Vella, Carlo Pavone, Vincenzo Serretta, Cristina Scalici Gesolfo, Chiara Sanfilippo, Chiara Carola Sanfilippo, Cristina Scalici Gesolfo, Davide Baiamonte, Loris Cacciatore

Risultato della ricerca: Articlepeer review

Abstract

Evidence that smoking cessation at first diagnosis of nonmuscle-invasive bladder cancer (NMIBC) reduces the risk of recurrence is lacking. The aim of our prospective study was to analyze the association between patients' changes in smoking habits after diagnosis and recurrence-free survival (RFS).
Lingua originaleEnglish
Numero di pagine6
RivistaUrologia Internationalis
Stato di pubblicazionePublished - 2020

All Science Journal Classification (ASJC) codes

  • Urology

Fingerprint Entra nei temi di ricerca di 'Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study'. Insieme formano una fingerprint unica.

Cita questo